Fuse Medical obtains waiver of EBITDA default; loan limit cut to $2.55M, term extended to Feb 2022

Fuse Medical, Inc.

Lender waived default for failing to meet $600K minimum EBITDA for trailing twelve months ended Sep 30, 2021.
Aggregate loan limit reduced to $2,550,000 from prior level.
Termination date extended to February 4, 2022; interest rate Prime + 1.00%.
President/Chairman Mark Brooks’ annual salary capped at $550,000 as part of amendment.
Company and guarantors released all claims against lender.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.